zurück

Glucarpidase (reduce toxic plasma methotrexate concentration in adults and children aged ≥ 28 days)


Subject:

  • Active Substance: Glucarpidase
  • Name: Voraxaze®
  • Therapeutic area: Toxic methotrexate plasma concentration
  • Pharmaceutical company: SERB GmbH


Time table:

  • Start: 15.04.2022
  • Final decision by G-BA: 06.10.2022


Final decision:

  • Hint for a non-quantifiable additional benefit